Compare VSTM & JRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VSTM | JRI |
|---|---|---|
| Founded | 2010 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 395.4M | 356.8M |
| IPO Year | 2011 | N/A |
| Metric | VSTM | JRI |
|---|---|---|
| Price | $5.89 | $12.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 113.3K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.38% |
| EPS Growth | ★ 17.49 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,914,000.00 | N/A |
| Revenue This Year | $282.64 | N/A |
| Revenue Next Year | $72.25 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 209.14 | N/A |
| 52 Week Low | $3.43 | $11.67 |
| 52 Week High | $11.25 | $14.37 |
| Indicator | VSTM | JRI |
|---|---|---|
| Relative Strength Index (RSI) | 67.17 | 50.34 |
| Support Level | $5.53 | $12.86 |
| Resistance Level | $6.48 | $13.04 |
| Average True Range (ATR) | 0.47 | 0.10 |
| MACD | 0.11 | -0.01 |
| Stochastic Oscillator | 85.31 | 15.70 |
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Nuveen Real Asset Income and Growth Fund is a closed-end fund. Its objective is to provide a high level of current income and long-term capital appreciation. The fund invests a majority of its managed assets in equity and debt securities issued by real asset related companies located anywhere in the world. Its plan involves investments in five security types, infrastructure common stock, REIT preferred stock and debt securities. Real asset-related companies include those engaged in owning, operating, or developing infrastructure projects, facilities, and services, as well as REITs.